Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice

Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice


  • Giorgio Ciprandi
  • Maria Angela Tosca
  • Irene Schiavetti
  • Roberta Olcese
  • Michele Miraglia del Giudice


Asthma, Children, FEF25-75


Background Reversible bronchial obstruction characterizes asthma. Spirometry is the gold standard to assess airflow, and FEV1 is the most reliable parameter in this regard. However, many children with asthma have FEV1 within the normal range despite uncontrolled asthma and worsening. Therefore, FEF25-75 has been proposed as a valuable marker of early airflow impairment. This study aimed at investigating FEF25-75 in a cohort of children with newly diagnosed asthma.

Methods 381 children (122 females, mean age 11.6 years) were consecutively visited and had a new asthma diagnosis. In addition, Spirometry, type-2 phenotyping, asthma control assessment, and ACT were performed.

Results 72 (18.9%) asthmatic children had impaired FEF25-75, such as <65% of predicted. Low FEF25-75 was associated with lower FVC and FEV1/FVC values (OR 1.11 and 1.32, respectively). Children with normal FEV1 but impaired FEF25-75 had more frequently uncontrolled asthma (15.8% vs. 32.4%) than children with both parameters within the normal range.

Conclusions FEF25-75 deserves adequate and careful consideration in children with asthma, and the presence of impaired FEF25-75 values suggests a more compelling approach.



Tosca MA, Schiavetti I, Duse M, Marseglia GL, Ciprandi G. A survey on the management of children with asthma in primary care setting in Italy. Ped Allergy Immunol Pulmonol 2021;34:39-42

Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, et al. “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J 2019;53:1800938

Global Initiative for Asthma. GINA guidelines. Global strategy for Asthma Management and Prevention. 2021. Available at: htpp:// Accessed on October 2021

Gaillard EA, Kuehni CE, Turner S, Goutaki M, Holden KA, de Jong CCM, et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years. Eur Respir J 2021:2004173

Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, et al. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. European Respiratory Journal 2021;57:2000289

Bush A. Lung Development and Aging. Ann Am Thorac Soc. 2016;Suppl 5:S438-S446

Simon MR, Chinchilli VM, Phillips BR, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010;126:527-34

Siroux V, Boudier A, Dolgopoloff M, Chanoine S, Bousquet J, Gormand F, et al. Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes. J Allergy Clin Immunol 2016;137:1709-16

Ciprandi G, Cirillo I. The pragmatic role of FEF(25-75) in asymptomatic subjects, allergic rhinitis, asthma, and in military setting. Expert Rev Respir Med. 2019;13(12):1147-1151

Kwon DS, Choi YJ, Kim TH, Byun MK, Cho JH, Kim HJ, et al. FEF(25-75%) Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2913-2921

Qin R, An J, Xie J, Huang R, Xie Y, He L, et al. FEF(25-75)% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF(25-75)% and FEV(1). J Allergy Clin Immunol Pract 2021;9(10):3649-3659.e6

Kong JK, Lee SH, Jung JY, Eom SY, Hahn YS. Clinical implications of the FEF(25-75) variability in childhood asthma. Ann Allergy Asthma Immunol. 2018;121(4):496-497

Liu X, Wang X, Yao X, Wang Y, Sun Y, Zhang L. Value of Exhaled Nitric Oxide and FEF(25-75) in Identifying Factors Associated With Chronic Cough in Allergic Rhinitis. Allergy Asthma Immunol Res. 2019;11(6):830-845

Szefler SJ, Goldstein S, Vogelberg C, Bensch GW, Given J, Jugovic B, et al. Forced Expiratory Flow (FEF(25-75%)) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis. Pulm Ther. 2020;6(2):151-158

Tosca MA, Marseglia GL, Ciprandi G; “ControL’Asma” Study Group. The real-world "ControL'Asma" study: a nationwide taskforce on asthma control in children and adolescents. Allergol Immunopathol (Madr). 2021;49(1):32-39

Ciprandi G, Gallo F, Cirillo I. FEF25-75 and Asthma in Clinical Practice. Iran J Allergy Asthma Immunol. 2018;17(3):295-297

Thomson NC, Chaudhuri R, Spears M, Messow CM, MacNee W, Connell M, et al. Poor symptom control is associated with reduced CT scan segmental airway lumen area in smokers with asthma. Chest. 2015;147:735-44

Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Tosca MA, et al. Role of FEF25-75 as predictor of bronchial hyperreactivity in allergic patients. Annals Allergy Asthma Immunology 2006;96:692-700

Ciprandi G, Capasso M, Leonardi S, Lionetti E, La Rosa M, Salpietro C, et al. Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma. J Bio Regulator 2012;26:19-26

Ciprandi G, Tosca MA, Cirillo I, Lionetti E, Leonardi S, Miraglia del Giudice M, et al. Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma. J Bio Regulator 2012;26:27-3







How to Cite

Ciprandi G, Tosca MA, Schiavetti I, Olcese R, Miraglia del Giudice M. Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice. Acta Biomed [Internet]. 2022 Aug. 31 [cited 2024 Jul. 24];93(4):e2022276. Available from: